Abstract
The literature on the distribution and function of serotonin in brain has grown enormously in the past 15 years. The authors do not consider it possible within limited space to document adequately all the evidence, hence they elect to give certain general references from which the reader can, with relative ease, get to the source. For those interested in tables of critical values, the Handbook of Experimental Pharmacology(11) will suffice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
N. Andén, A. Dahlström, K. Fuxe, and K. Larsson, Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon, Life Sci. 4:1275–1279(1965).
N. Andén and T. Magnusson, An improved method for the fluorometric determination of 5-hydroxytryptamine in tissues, Acta Physiol. Scand. 69:87 (1967).
J. Axelrod, in Mechanisms of Release of Biogenic Amines, p. 189, Pergamon Press, New York (1966).
F. Berti and P. A. Shore, A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pump, Biochem. Pharmacol. 16:2091–2094 (1967).
B. B. Brodie, M. S. Comer, E. Costa, and A. Olabac, The role of brain serotonin in the mechanism of the central action of reserpine, J. Pharmacol. Exp. Therap. 152:340–349 (1965).
A. Carlsson, in Handbook of Experimental Pharmacology (O. Eichler and A. Farah, eds.), Springer-Verlag, New York (1965).
A. Carlsson, B. Falck, and N. Hillarp, Cellular localization of brain monoamines, Acta Physiol. Scand. 56:Suppl. 196 (1962).
A. Carlsson, K. Fuxe, B. Hamberger, and M. Lindqvist, Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons, Acta Physiol. Scand. 67:481–497 (1966).
E. Costa, The role of serotonin in neurobiology, Int. Rev. Neurobiol. 2:175 (1960).
A. Dahlström and K. Fuxe, Evidence for the existence of monoamine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems; and K. Fuxe, IV. Distribution of monoamine nerve terminals in the central nervous system, Acta Physiol. Scand. 64:Suppl. 247 (1965).
Handbook of Experimental Pharmacology (O. Eichler and A. Farah, eds.), Springer-Verlag, New York (1965).
K. Engelman, W. Lovenberg, and A. Sjoerdsma, Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome, New Eng. J. Med. 277:1103–1108(1967).
V. Erspamer, Pharmacology of indolealkylamines, Pharmacol. Rev. 6:427–587 (1954).
V. Erspamer, in Progress in Drug Research (E. Jucker, ed.), pp. 151–367, Interscience Publ., New York (1961).
V. Erspamer, ed. Handbook of Experimental Pharmacology, Springer-Verlag, New York (1965).
U. S. von Euler, S. Roseli, and B. Uvnäs, Mechanisms of Release of Biogenic Amines, Pergamon Press, Oxford (1966).
S. Garratini and L. Valzelli, Serotonin, Elsevier, Amsterdam (1965).
B. Falck, in Progress in Brain Research (H. E. and W. A. Himwich, eds.), Vol. 8, pp. 28–44, Elsevier, Amsterdam (1964).
S. Kveder, S. Iskric, and D. Keglević, 5-Hydroxytryptophol: a metabolite of 5-hydroxytryptamine in rats, Biochem. J. 85:447–449 (1962).
W. Lovenberg, E. Jequier, and A. Sjoerdsma, Tryptophan hydroxylation: measurement in pineal gland, brainstem and carcinoid tumor, Science 155:217–219 (1967).
T. E. Mansour, Effect of hormones on carbohydrate metabolism of invertebrates, Fed. Proc. 26:1179–1185(1967).
I. H. Page, Serotonin (5-hydroxytryptamine), Physiol. Rev. 34:563–588 (1954).
I. H. Page, Serotonin (5-hydroxytryptamine); the last four years, Physiol. Rev. 38:277–335 (1958).
A. Pletscher, P. A. Shore, and B. B. Brodie, Serotonin as a mediator of reserpine action in brain, J. Pharmacol. Exp. Therap. 116:84–89 (1956).
W. B. Quay, Orcadian rhythm in rat pineal serotonin and its modifications by estrous cycle and photoperiod, Gen. Comp. Endocrinol. 3:473–479 (1963).
G. P. Quinn, P. A. Shore, and B. B. Brodie, Biochemical and pharmacological studies on Ro 1–9569 (tetrabenazine) a non-indole tranquilizing agent with reserpine-like effects, J. Pharmacol. Exp. Therap. 127:103 (1959).
A. Sjoerdsma, Serotonin, New Eng. J. Med. 261:181 (1959).
L. Sollero, Serotonina e Substâncias Antitriptamínicas, Universidade do Brasil, Rio de Janeiro (1963).
P. Stark, E. S. Boyd, and R. W. Fuller, A possible role of serotonin in hypothalamic self-stimulation in dogs, J. Pharmacol. Exp. Therap. 146:147–153 (1964).
J. R. Vane, The use of isolated organs for detecting active substances in the circulating blood, Brit. J. Pharmacol. Chemotherap. 23:360 (1964).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Plenum Press, New York
About this chapter
Cite this chapter
Page, I.H., Carlsson, A. (1970). Serotonin. In: Lajtha, A. (eds) Control Mechanisms in the Nervous System. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7163-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7163-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7165-0
Online ISBN: 978-1-4615-7163-6
eBook Packages: Springer Book Archive